KPW
RCKT icon

Kore Private Wealth’s Rocket Pharmaceuticals RCKT Stock Holding History

Kore Private Wealth’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,750
Closed -$36K – 885
2020
Q2 		$36K Hold
1,750
– – 0.01% 529
2020
Q1 		$24K Buy
1,750
+1,000
+133% +$19.8K 0.01% 560
2019
Q4 		$17K Buy
+750
New +$12.5K ﹤0.01% 656

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Kore Private Wealth's RCKT Position: Q3 2020 in Review

Kore Private Wealth sold out of Rocket Pharmaceuticals (RCKT) in Q3 2020, closing a stake of 1,750 shares — an estimated $36K sold.

Kore Private Wealth first reported a position in RCKT in Q4 2019 and held it in 3 quarters. The position peaked at $36K in Q2 2020. 126 funds tracked by Wall St. Rank hold RCKT as of Q3 2020.

  • Kore Private Wealth reported no remaining Rocket Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Kore Private Wealth sold 1,750 Rocket Pharmaceuticals shares in Q3 2020, an estimated $36K.
  • Kore Private Wealth first reported a position in Rocket Pharmaceuticals in Q4 2019 and held it in 3 quarters.
  • Kore Private Wealth's Rocket Pharmaceuticals position peaked at $36K in Q2 2020.
  • 126 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2020.

Based on Kore Private Wealth's 13F filing for Q3 2020, filed 13 Nov 2020.